Oslo universitetssykehus, Rikshospitalet

Oslo N-0372

1 studies enrolling now · 10 studies all time

What they study most

Acute Lymphoblastic Leukemia (ALL), Allogeneic Hematopoietic Stem Cell Transplantation, Crohn Disease, Crohn's Disease, Heart Failure With Preserved Ejection Fraction (HFpEF), Hemophilia A, Multiple Myeloma, Myocardial Infarction, Sudden Death, Tachycardia, Ventricular Arrythmia

Studies at this site

• ELEVATE-HFpEF Clinical Study — Recruiting now
• A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A — Completed
• Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia — Completed
• Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction — Completed
• Extravascular ICD Pivotal Study — Completed
• Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma — Completed
• BAX 802 in CHA With Inhibitors — Stopped early
• Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early
• A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) — Stopped early
• A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease — Stopped early